Kim Peter W, Harris Anthony D, Roghmann Mary-Claire, Morris J Glenn, Strinivasan Arjun, Perencevich Eli N
Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Antimicrob Agents Chemother. 2003 Sep;47(9):2882-7. doi: 10.1128/AAC.47.9.2882-2887.2003.
Antimicrobial resistance is an emerging problem among nosocomial bacteria. Risk factors for the recovery of ceftriaxone-resistant (CRCF) or -susceptible (CSCF) Citrobacter freundii in clinical cultures from hospitalized patients were determined by using a case-case-control study design. CRCF was isolated from 43 patients (case group 1) and CSCF was isolated from 87 patients (case group 2) over a 3-year period. Risk factors for CRCF were exposure to imipenem (odds ratio [OR], 7.5; 95% confidence interval [CI], 1.2 to 45.4), broad-spectrum cephalosporins (OR, 6.9; 95% CI, 1.8 to 26.7), vancomycin (OR, 3.0; 95% CI, 1.2 to 7.4), or piperacillin-tazobactam (OR, 2.6; 95% CI, 1.1 to 6.2), as well as hospital length of stay >or=1 week (OR, 3.6; 95% CI, 1.3 to 10.2) and intensive care unit (ICU) stay (OR, 2.6; 95% CI, 1.1 to 6.2). Risk factors for CSCF were peripheral vascular disease (OR, 23.2; 95% CI, 4.3 to 124.6), AIDS (OR, 9.5; 95% CI, 1.6 to 55.5), cerebrovascular disease (OR, 4.2; 95% CI, 1.6 to 10.8), and ICU stay (OR, 3.1; 95% CI, 1.8 to 5.4).
抗菌药物耐药性是医院细菌中一个新出现的问题。采用病例 - 病例 - 对照研究设计确定了住院患者临床培养物中分离出耐头孢曲松(CRCF)或对头孢曲松敏感(CSCF)的弗氏柠檬酸杆菌的危险因素。在3年期间,从43例患者中分离出CRCF(病例组1),从87例患者中分离出CSCF(病例组2)。CRCF的危险因素包括使用亚胺培南(比值比[OR],7.5;95%置信区间[CI],1.2至45.4)、广谱头孢菌素(OR,6.9;95%CI,1.8至26.7)、万古霉素(OR,3.0;95%CI,1.2至7.4)或哌拉西林 - 他唑巴坦(OR,2.6;95%CI,1.1至6.2),以及住院时间≥1周(OR,3.6;95%CI,1.3至10.2)和入住重症监护病房(ICU)(OR,2.6;95%CI,1.1至6.2)。CSCF的危险因素包括外周血管疾病(OR,23.2;95%CI,4.3至124.6)、艾滋病(OR,9.5;95%CI,1.6至55.5)、脑血管疾病(OR,4.2;95%CI,1.6至10.8)和入住ICU(OR,3.1;95%CI,1.8至5.4)。